Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
New Board of Directors and management team at Suven Pharma also appointed
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
The company has received the Establishment Inspection Report (EIR) from the USFDA for the Pre-Approval Inspection (PAI) at a manufacturing site situated at Savli, Vadodara, Gujarat, with Zero 483 observations
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Eris Lifesciences enters into term loan agreement with Citi Bank
Subscribe To Our Newsletter & Stay Updated
